• Peepattra is a graduate of the Faculty of Pharmaceutical Sciences, at Chulalongkorn University. After working at King Chulalongkorn Memorial Hospital, she continued her studies in the field of pharmaceutical care. Her previous experience at a clinical research center allows her to contribute her first-hand knowledge of conducting clinical trials to Baiya Phytopharm’ s mission.
• Peepattra joined Baiya Phytopharm since September 2021, overseeing the clinical trials of the Baiya SARS-CoV-2 Vax 1 vaccine. As the leader of the clinical research team, she embraces the challenges of adjusting to the unknown situations that may occur during the research process. Her collaboration with various organizations sets up the clinical trial that began the terminating step of Baiya Phytopharm’ s first endeavor.
Achievement: Peepattra has successfully managed and executed clinical trials for Baiya SARS-CoV-2, resulting in completion of all milestones within the allocated budget and timeline. Peepattra provided diligent oversight of clinical monitoring to ensure data integrity, patient safety, and adherence to protocol, thereby securing regulatory compliance throughout all trials. This approach ultimately resulted in the successful completion of clinical trial operation for collective data in accordance with study objectives, leading to further submission of IND regulatory application.